Actinic Keratosis in Korea: Skin Cancer Risk Guide

Actinic Keratosis in Korea: Skin Cancer Risk Guide

A rough, dry patch on the face, ears, or the backs of the hands that feels more noticeable to the touch than it looks to the eye is often the first sign of actinic keratosis. It's one of the most common findings dermatologists see in sun-exposed skin, and unlike most of the growths covered in general dermatology, this one is specifically considered a precancerous change — a distinction that makes it worth understanding clearly rather than dismissing as just another age-related skin spot.

This guide covers what actinic keratosis is, what the actual research says about its risk of progressing to skin cancer, and what evaluation and treatment look like at dermatology clinics in Busan.

What Is Actinic Keratosis?

Actinic keratosis (AK) is a precancerous skin lesion caused by long-term, cumulative exposure to ultraviolet radiation. It commonly develops on chronically sun-exposed areas — the face, ears, scalp, neck, forearms, and the backs of the hands — and becomes increasingly common with age, reflecting years of accumulated UV exposure.

AK is considered an early step in the development of squamous cell carcinoma (SCC), one of the more common forms of skin cancer, though the relationship between the two is nuanced rather than a simple guarantee of progression.

Symptoms and Appearance

• Rough, dry, scaly patches, often described as feeling like sandpaper
• Color ranging from skin-toned to pink, red, brown, or grayish, depending on skin tone
• Patches that may be more noticeable by touch than by sight in early stages
• Size typically ranging from a few millimeters to around a centimeter, though patches can merge into larger areas
• Occasional itching, tenderness, or a burning or stinging sensation
• A tendency to appear as multiple lesions across a broader area of sun-damaged skin, a pattern sometimes called field cancerization

What Does "Precancerous" Actually Mean Here?

This is the part that causes the most confusion, and it's worth being precise about. Actinic keratosis is not the same as skin cancer, and the majority of individual AK lesions never progress to invasive squamous cell carcinoma. Research estimates the annual risk of any single lesion progressing at somewhere between roughly 0% and just over half a percent, and some studies suggest even lower per-lesion rates. Spontaneous regression of individual lesions without any treatment has also been documented in a meaningful share of cases.

However, two things change the overall picture. First, most people with AK have multiple lesions rather than just one, and even a small individual risk becomes more significant when multiplied across many lesions and years. Second, in patients followed over several years, cumulative progression rates rise meaningfully — one analysis found the risk climbing from roughly half a percent annually to over two and a half percent within four years among older patients with multiple lesions. It's also currently not possible to predict, just by looking at or biopsying a given lesion, which ones will eventually progress and which won't. This unpredictability is the main reason dermatologists generally recommend treating AK rather than simply monitoring it.

Risk Factors

• Cumulative lifetime UV exposure, including sunburns and long-term unprotected sun exposure
• Lighter skin tone, though AK can occur in people of any skin type with sufficient sun exposure
• Older age
• A weakened immune system, including immunosuppression after organ transplantation, which significantly raises both AK and SCC risk
• A personal history of AK or skin cancer
• Occupational or lifestyle sun exposure, such as extensive outdoor work or recreation

Diagnosis

Most actinic keratosis is diagnosed through visual examination and dermoscopy, given its characteristic rough, scaly appearance in classic sun-exposed locations. A dermatologist will typically examine the entire area of sun-damaged skin, not just the specific spot a patient is concerned about, since AK frequently appears as multiple lesions across a broader field rather than in isolation.

A biopsy may be recommended if a lesion is thickened, rapidly growing, tender, bleeding, or otherwise looks atypical, since these features can suggest a lesion has already progressed toward or into invasive squamous cell carcinoma, which requires a different treatment approach entirely.

Treatment Options

Current clinical guidance generally recommends treating actinic keratosis lesions rather than simply observing them, given the inability to predict which ones might progress. Treatment approaches fall into two broad categories.

Lesion-Directed Treatment

For a small number of isolated lesions, cryotherapy — freezing the spot with liquid nitrogen — is one of the most common and well-established approaches, typically causing the lesion to blister and shed within a couple of weeks.

Field-Directed Treatment

When multiple lesions are present across a broader area of sun-damaged skin, field-directed treatments are often more appropriate, since they address visible lesions as well as subclinical damage in the surrounding skin. Options include:

• Topical 5-fluorouracil (5-FU): An established topical chemotherapy cream applied over a course of days to weeks, effective for treating broader areas of sun damage
• Imiquimod: A topical immune-response modifier applied over several weeks
• Tirbanibulin: A newer topical treatment applied over a short, five-day course, studied for both standard and thicker, more scaly (hyperkeratotic) lesions
• Photodynamic therapy (PDT): A photosensitizing solution is applied to the skin and then activated with a specific light source in-clinic, which selectively targets damaged cells
• Chemical peels: Can be used in some cases to address a broader field of sun damage alongside more classic AK treatment

The choice between lesion-directed and field-directed treatment, or a combination of both, depends on how many lesions are present, their thickness, their location, and individual patient factors, and is best decided together with a dermatologist rather than through a one-size-fits-all approach.

Follow-Up and Long-Term Monitoring

Because new actinic keratosis lesions can continue to develop on chronically sun-damaged skin, and because early squamous cell carcinoma can sometimes resemble a stubborn AK lesion, regular follow-up skin checks are an important part of long-term management, particularly for people with a history of multiple lesions, significant sun exposure, or immunosuppression.

Prevention

• Daily broad-spectrum sunscreen use, reapplied regularly during extended outdoor exposure
• Protective clothing, wide-brimmed hats, and seeking shade during peak UV hours
• Avoiding tanning beds and intentional sunbathing
• Regular skin self-checks to catch new or changing lesions early
• Scheduled dermatology visits, particularly for those with a history of significant sun exposure or previous AK diagnosis

When to Seek Prompt Evaluation

• A lesion that becomes thickened, tender, or rapidly growing
• A spot that bleeds, ulcerates, or doesn't heal
• A previously stable lesion that suddenly changes in appearance
• Multiple new lesions appearing over a short period
• Any lesion in someone with a weakened immune system, given the higher associated risk

Why Choose Busan for Actinic Keratosis Care

Dermatology clinics and hospitals in Busan offer both lesion-directed and field-directed treatment options for actinic keratosis, including newer topical agents where available, along with dermoscopy and biopsy capability for confirming diagnosis when needed. International patients can generally access prompt appointments, with English-speaking support at many international-facing clinics, which is useful for a condition that benefits from timely evaluation and ongoing monitoring.

Tips for International Patients

• Mention your history of sun exposure, including significant sunburns, tanning, or years spent in high-UV environments or outdoor occupations
• Ask whether a full-body or full-field skin check is appropriate given your history, rather than evaluating a single spot in isolation
• If you have multiple lesions, ask whether field-directed treatment might be more appropriate than treating each spot individually
• If you have a weakened immune system or history of organ transplantation, mention this clearly, since it affects both risk level and monitoring frequency
• Schedule regular follow-up skin checks even after successful treatment, since new lesions can develop on chronically sun-damaged skin over time

Frequently Asked Questions

Does actinic keratosis always turn into skin cancer?

No. The risk of any single lesion progressing to invasive squamous cell carcinoma is generally low, though it rises when a person has multiple lesions and is followed over several years. Because it's not currently possible to predict which specific lesions will progress, dermatologists generally recommend treating rather than only observing AK.

Is actinic keratosis the same as skin cancer?

No, though it's closely related. AK is considered a precancerous change, meaning it carries elevated risk, but it is distinct from invasive squamous cell carcinoma itself.

What's the difference between treating one spot and treating a whole area?

Lesion-directed treatment, like cryotherapy, targets individual visible spots, while field-directed treatment, using topical creams or photodynamic therapy, addresses a broader area of sun-damaged skin, including subclinical changes not yet visible. The right choice depends on how many lesions are present and their distribution.

How often should I get a skin check if I have actinic keratosis?

This depends on your individual risk factors, including how many lesions you've had, your overall sun exposure history, and your immune status. A dermatologist can recommend an appropriate follow-up schedule for your specific situation.

Can actinic keratosis go away on its own?

Some individual lesions have been documented to regress spontaneously without treatment, but since it's not possible to predict which lesions will resolve versus progress, most dermatologists recommend active treatment rather than waiting to see what happens.

Is it too late to prevent more actinic keratosis if I already have some?

No. Consistent sun protection going forward can still reduce the development of new lesions and slow further sun damage, even in someone who already has existing AK.

Conclusion

Actinic keratosis sits in an important middle ground — not skin cancer itself, but a recognized marker of cumulative sun damage with a real, if often low, individual risk of progressing to squamous cell carcinoma. Because that risk is impossible to predict lesion by lesion, and because cumulative risk rises meaningfully with multiple lesions over time, most dermatologists recommend treating AK rather than simply watching it. A dermatologist in Busan can help determine the most appropriate lesion-directed or field-directed treatment for your specific pattern of sun damage, along with a sensible long-term monitoring plan.